Has Heather Newlon, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,280 in general payments to Heather Newlon, MD across 162 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Heather Newlon, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Heather Newlon, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Heather Newlon, MD

Dermatology · McComb, MSNPI 1427278894

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,888 of the $3,280 with a category attached, or 88.1%. It is spread thinly across 24 manufacturers, the largest accounting for just 16.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $910, 4.5 times the $202 reported in 2019. That places this record below the midpoint for dermatology clinicians in MS, where the typical reported total is $4,621.

$3,280in general payments, 2019–2025

Across 162 payments — averaging $20.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$524
Johnson & Johnson$521
AbbVie$370
Hill Dermaceuticals, Inc.$240
Incyte Corporation$239
Sanofi$235
plus $1K from 18 others

What the payments were for

Food & beverage$2,88888%
Education$39212%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	42	$524
Johnson & Johnson	22	$521
AbbVie	18	$370
Hill Dermaceuticals, Inc.	1	$240
Incyte Corporation	15	$239
Sanofi	14	$235
LEO Pharma Inc.	7	$165
Almirall LLC	7	$153
Pfizer	4	$136
E.r. Squibb & Sons, L.L.C.	5	$108
Sun Pharmaceutical Industries Inc.	3	$96
Ortho Dermatologics, A Division Of Bausch Health US, LLC	5	$86
Regeneron Healthcare Solutions, Inc.	4	$85
Sanofi-aventis U.S. LLC	1	$65
UCB, Inc.	2	$53
Botanix SB Inc	2	$39
Blueprint Medicines Corporation	2	$37
Journey Medical Corporation	2	$32
Dermavant Sciences, Inc.	1	$22
Medimetriks Pharmaceuticals, Inc.	1	$18
Smith+Nephew	1	$15
Galderma Laboratories, L.p.	1	$14
Fresenius Kabi USA, LLC	1	$14
Sandoz	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Tolak$240

How this compares

$3,280 in reported general payments places this provider in the 40th percentile of 78 dermatology providers in Mississippi.

See all dermatology providers in Mississippi →

Medicare billing

Part B allowed, 2024

$452,627

Medicare patients

1,469

Services billed

9,993

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OtezlaApremilast	12	$56,164
Clobetasol Propionate	73	$2,541
Betamethasone Valerate	31	$1,185
Doxycycline Hyclate	82	$999
Metronidazole	14	$901
Fluorouracil	13	$880
Triamcinolone Acetonide	131	$771
Ketoconazole	11	$233
Mupirocin	18	$120
Fluconazole	13	$50

Paid to pharmacies, not to this prescriber.

Other dermatology in McComb

James BrockMcComb$2K
Jeremy JacksonJackson$450K
Lindsey ZubritskyOcean Springs$349K
Maureen OffiahHattiesburg$275K
Lyndsay ShippOxford$246K
Steven ShapiroHattiesburg$165K
Joseph TerracinaGreenville$86K
Thy HuynhJackson$51K
Patrick BolerClinton$44K
Jeffrey HouinTupelo$27K

See the full list for Mississippi →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →